Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure

JACC: Heart Failure

Volumn 4, Issue 2, 2016, Pages 95-105

  Costanzo, Maria Rosa ^a   Negoianu, Daniel ^b   Jaski, Brian E ^c   Bart, Bradley A ^d   Heywood, James T ^e   Anand, Inder S ^f   Smelser, James M ^g   Kaneshige, Alan M ^h   Chomsky, Don B ⁱ   Adler, Eric D ^j   Haas, Garrie J ^k   Watts, James A ^l   Nabut, Jose L ^m   Schollmeyer, Michael P ^m   Fonarow, Gregg C ⁿ  

^a Edward Heart Hospital   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c SHARP MEMORIAL HOSPITAL   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

^e SCRIPPS CLINIC   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g Huntsville Renal Clinic   (United States)

^h Oklahoma Heart Institute   (United States)

ⁱ Saint Thomas Heart Hospital   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k OHIO STATE UNIVERSITY   (United States)

^l BROOKE ARMY MEDICAL CENTER   (United States)

^m BAXTER HEALTHCARE CORPORATION   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Aquapheresis; Congestion; Fluid overload; Heart failure; Hospitalizations; Loop diuretics; Worsening renal function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HEPARIN; LOOP DIURETIC AGENT; VASOACTIVE AGENT;

ACCESS SITE INFECTION; ACUTE CORONARY SYNDROME; ADJUSTABLE ULTRAFILTRATION; AGED; AQUAPHERESIS; ARTICLE; CARDIOGENIC SHOCK; CARDIORENAL SYNDROME; CONTROLLED STUDY; DEHYDRATION; FAINTNESS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART DEATH; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MORTALITY; MULTICENTER STUDY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RENAL HEMATOMA; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; THORAX PAIN; TIME TO TREATMENT; TREATMENT OUTCOME; ULTRAFILTRATION; CLINICAL TRIAL; DOSE RESPONSE; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; TIME FACTOR; TRENDS;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 84959162739     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.08.005     Document Type: Article

References (20)

1. Lee D.S., Austin P.C., Stukel T.A., et al. "Dose-dependent" impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med 2009, 122:162-169.
2. Setoguchi S., Stevenson L.W., Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007, 154:260-266.
3. Konstam M.A., Gheorghiade M., Burnett J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297:1319-1331.
4. Massie B.M., O'Connor C.M., Metra M., et al. Rolofylline, an adenosine a1-receptor antagonist, in acute heart failure, for the Protect Investigators and Committees. N Engl J Med 2010, 363:1419-1428.
5. Felker G.M., Lee K.L., Bull D.A., et al. Diuretic strategies in patients with acute decompensted heart failure. N Engl J Med 2011, 364:797-805.
6. O'Connor C.M., Starling R.C., Hernandez A.F., et al. Effect of nesiritide in patients with Acute Decompensated Heart Failure (ASCEND-HF). N Engl J Med 2011, 365:32-43.
7. Costanzo M.R., Chawla L.S., Tumlin J.A., et al. The role of early and sufficient isolated venovenous ultrafiltration in heart failure patients with pulmonary and systemic congestion. Rev Cardiovasc Med 2013, 14:123-133.
8. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49:675-683.
9. Bart B.A., Goldsmith S.R., Lee K.L., et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012, 367:2296-2304.
10. Ali S.S., Olinger C.C., Sobotka P.A., et al. Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion. Congest Heart Fail 2009, 15:1-4.
11. Agostoni P., Marenzi G., Lauri G., et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994, 96:191-199.
12. Marenzi G., Muratori M., Cosentino E.R., et al. Continuous ultrafiltration for congestive heart failure. The CUORE Trial. J Card Fail 2014, 20:9-17.
13. Costanzo M.R., Negoianu D., Fonarow G.C., et al. Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart 4 Failure (AVOID-HF) trial. Am Heart J 2015, 170:471-482.
14. Patarroyo M., Wehbe E., Hanna M., et al. Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. J Am Coll Cardiol 2012, 60:1906-1912.
15. Hernandez A.F., Greiner M.A., Fonarow G.C., et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 2010, 303:1716-1722.
16. Lorenz J.N., Weihprecht H., Schnermann J., Skott O., Briggs J.P. Renin release from isolated juxtaglomerular apparatus depends on macula densa chloride transport. Am J Physiol 1991, 260:F486-F493.
17. Marenzi G., Grazi S., Giraldi F., et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 1993, 94:49-56.
18. Bram B., Cupples W.A., Joles J.A., Gaillard C. Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev 2012, 17:161-175.
19. Tahhan A.S., Vaduganathan M., Kelkar A., et al. Trends in heart failure clinical trials from 2001-2012. J Card Fail 2015, In press. http://dx.doi.org/10.1016/j.cardfail.2015.06.014.
20. Tang W.H.W. Reconsidering ultrafiltration in the acute cardiorenal syndrome. N Engl J Med 2012, 367:2351-2352.